Status:

COMPLETED

Evaluation of Left Ventricular Autothreshold, Phase Two

Lead Sponsor:

Boston Scientific Corporation

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

This study will collect data, from an implanted Cardiac Resynchronization Therapy-Defibrillator (CRT-D) device, to further evaluate a new feature for future heart failure devices.

Detailed Description

ELEVATE 2.0 is an acute, prospective, multi-center, feasibility study randomized within patient test sequence and pulse width, designed to characterize the performance of the Left Ventricular Auto Thr...

Eligibility Criteria

Inclusion

  • Patients who have a COGNIS CRT-D device implanted for at least 24 hours, with or without a right atrial lead
  • Patients who have an active LV bipolar lead
  • Patients who have an active right ventricular (RV) defibrillation lead
  • Patients who are willing and capable of participating in all testing associated with this Clinical Investigation
  • Patients who are age 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion

  • Patients who have a COGNIS CRT-D that has less than or equal to one year of battery life remaining
  • Patients who are pacemaker-dependent
  • Patients who will not tolerate a pacing pause of up to 6 seconds
  • Patients who have a unipolar LV pace/sense lead, unless the patient has any commercially available epicardial leads with at least two electrodes (from one or more leads)
  • Patients with pre-existing leads other than those specified in this investigational plan
  • Patients with a pre-existing unipolar pacemaker
  • Patients who are unable or unwilling to maintain a supine or sitting position for 40-50 minutes
  • Patients enrolled in any concurrent study, without Boston Scientific written approval
  • Women who are pregnant

Key Trial Info

Start Date :

November 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2011

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01242722

Start Date

November 1 2010

End Date

March 1 2011

Last Update

October 3 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Regional Cardiovascular Medical Center

Stuebenville, Ohio, United States, 43952